Abstract
Introduction
Morbid obesity is well known as a risk factor for gastroesophageal reflux disease (GERD) and its related disorders such as Barrett’s esophagus (BE). This study aimed to evaluate the development of BE in patients who underwent bariatric surgery.
Materials and Methods
Using a single-center prospectively established database of obese patients who underwent bariatric surgery from 01/2012 to 12/2019, we retrospectively compared the preoperative endoscopic findings of BE to those after 1–2 years and 3–5 years following bariatric surgery. The change of BE was detected endoscopically according to Prague classification and histologically according to the British guidelines of detecting columnar epithelium on the distal esophagus.
Results
Among 914 obese patients who underwent bariatric surgery and received a preoperative esophagogastroduodenoscopy (EGD), we found 119 patients (13%) with BE. A follow-up EGD was performed in 74 of the BE patients (62.2%). A total of 37 (50%) patients underwent a follow-up EGD after 1–2 years and 45 (60.8%) patients underwent it after 3–5 years. Among many clinical parameters, the surgical procedure was the only significant factor for the change of BE after bariatric surgery (p < 0.05). A regression of BE was found in 19 patients (n = 54, 35%) after laparoscopic Roux-en-Y- gastric bypass (LRYGB). Furthermore, a progression of BE was detected in six patients (n = 20, 30%) after laparoscopic sleeve gastrectomy (LSG).
Conclusion
RYGB should be considered in obese patients with BE. Detecting BE prior to bariatric surgery may have an impact on decision-making regarding the suitable surgical bariatric procedure.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06829-3/MediaObjects/11695_2023_6829_Fig5_HTML.png)
Similar content being viewed by others
Data Availability
Study Data are available by the corresponding author.
References
El-Serag HB, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243–50.
Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am. 2014;43(1):161–73.
Herbella FA, et al. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg. 2007;11(3):286–90.
Moulla Y, et al. Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional? Obes Surg. 2020;30(6):2076–84.
Peromaa-Haavisto P, Victorzon M. Is routine preoperative upper GI endoscopy needed prior to gastric bypass? Obes Surg. 2013;23(6):736–9.
Goonawardena J, Ward S. Effect of Roux-en-Y gastric bypass on Barrett’s esophagus: a systematic review. Surg Obes Relat Dis. 2021;17(1):221–30.
Braghetto I, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22(5):764–72.
Madalosso CA, et al. The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Morbidly Obese Patients. Ann Surg. 2016;263(1):110–6.
Felsenreich DM, et al. Update: 10 Years of Sleeve Gastrectomy-the First 103 Patients. Obes Surg. 2018;28(11):3586–94.
Felsenreich DM, et al. Reflux, Sleeve Dilation, and Barrett’s Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up. Obes Surg. 2017;27(12):3092–101.
Qumseya BJ, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343-352 e2.
Shaheen NJ, et al. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol. 2016;111(1):30–50 quiz 51.
Nayar DS, Vaezi MF. Classifications of esophagitis: who needs them? Gastrointest Endosc. 2004;60(2):253–7.
Sharma P, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.
Fitzgerald RC, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.
Regan JP, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861–4.
Moulla Y, et al. Feasibility and Safety of Bariatric Surgery in High-Risk Patients: A Single-Center Experience. J Obes. 2018;2018:7498258.
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53(9):2307–12.
Ooi GJ, et al. Perioperative screening, management, and surveillance of Barrett’s esophagus in bariatric surgical patients. Ann N Y Acad Sci. 2020;1481(1):224–35.
El-Serag HB, et al. Abdominal obesity and the risk of Barrett’s esophagus. Am J Gastroenterol. 2005;100(10):2151–6.
Koop H, et al. S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021–013. Z Gastroenterol. 2014;52(11):1299–346.
Brown WA, et al. IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures. Obes Surg. 2020;30(8):3135–53.
Mansour NM, El-Serag HB, Anandasabapathy S. Barrett’s esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg. 2017;6(2):75–87.
Yanes M, et al. Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett’s oesophagus: multinational cohort study. Br J Surg. 2021;108(7):864–70.
Abdelrahman T, et al. Outcomes after laparoscopic anti-reflux surgery related to obesity: A systematic review and meta-analysis. Int J Surg. 2018;51:76–82.
Bashir Y, et al. Systematic review and meta-analysis on the effect of obesity on recurrence after laparoscopic anti-reflux surgery. Surgeon. 2019;17(2):107–18.
Csendes A, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.
Cobey F, Oelschlager B. Complete regression of Barrett’s esophagus after Roux-en-Y gastric bypass. Obes Surg. 2005;15(5):710–2.
Gorodner V, et al. Barrett’s esophagus after Roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.
Andrew B, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.
Signorini F, et al. Impact of Gastric Bypass on Erosive Esophagitis and Barret’s Esophagus. Obes Surg. 2020;30(4):1194–9.
Angrisani L, et al. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obes Surg. 2021;31(5):1937–48.
Angrisani L, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018;28(12):3783–94.
Melissas J, et al. Gastroesophageal Reflux Disease and Sleeve Gastrectomy. Obes Surg. 2015;25(12):2430–5.
Yeung KTD, et al. Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?: A Systematic Review and Meta-analysis. Ann Surg. 2020;271(2):257–65.
Elkassem S. Gastroesophageal Reflux Disease, Esophagitis, and Barrett’s Esophagus 3 to 4 Years Post Sleeve Gastrectomy. Obes Surg. 2021;31(12):5148–55.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
For this type of study, formal consent is not required.
Conflict of Interest
The authors declare they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
Preoperative EGD has a significant impact on the choice of bariatric procedure.
RYGB is recommended in obese patients with BE.
Structured surveillance with EGD after LSG should be considered in patients with BE.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Moulla, Y., Hamadeh, H., Seidemann, L. et al. Barrett`s Esophagus in Bariatric Surgery: Regression or Progression?. OBES SURG 33, 3391–3401 (2023). https://doi.org/10.1007/s11695-023-06829-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06829-3